Eli Lilly and Company is a global pharmaceutical company founded in 1876 in Indianapolis, Indiana, with approximately 48,000 employees operating worldwide. The company focuses on discovering, developing, and manufacturing medicines across multiple therapeutic areas, including diabetes care and obesity treatments. With nearly 150 years of operation, Lilly maintains research and development facilities that advance drug discovery and pharmaceutical R&D capabilities.
The company's technical operations span drug discovery, drug development, and patient-centered research programs. Lilly works across numerous therapeutic areas, applying scientific rigor to address complex health challenges. The organization's approach combines pharmaceutical research methodologies with manufacturing capabilities to develop treatments that meet documented patient needs. Development processes incorporate listening to patients and understanding real-world requirements to inform product design and delivery.
Under CEO David Ricks, the company operates with a stated commitment to quality and integrity established at its founding. Lilly's business model emphasizes growing operations in ways designed to benefit both patients and broader society, while maintaining focus on creating medicines that address identified medical needs across its global footprint.